Table 1.
ACE2 and B0AT1 Tissue Expression
Protein | Organ or tissue expression | Cell type | Assay | Involvement with COVID-19 | Author (year) |
---|---|---|---|---|---|
ACE2 | Esophagus | Epithelial cells | scRNA-seq | Contributes to virus spread and immunopathology in airways and intestinal system | Zou et al. (2020) [11] |
Intestine | Enterocytes and intestinal villi | scRNA-seq | Indicates an intrinsic susceptibility of intestine to SARS-CoV-2 infection and replication | Zou et al. (2020) [11], Hamming et al. (2004) [10] | |
Oral cavity | Epithelial cells | RNA-seq | Potential route of SARS-CoV-2 infection | Xu et al. (2020) [19], Zou et al. (2020) [11] | |
Stomach | Epithelial cells | scRNA-seq | Potential route of SARS-CoV-2 infection | Zou et al. (2020) [11] | |
Intestine | Enterocytes and intestinal villi | Western blot | Modulates the diarrhea that occurs in up to 39% of COVID-19 cases | Jando et al. (2017) [20] | |
B0AT1 | Intestine | Enterocytes and intestinal villi | Western blot | Modulates the diarrhea that occurs in up to 39% of COVID-19 cases | Jando et al. (2017) [20] |
ACE2, angiotensin-converting enzyme 2; COVID-19, coronavirus disease; scRNA, single cell RNA; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.